Transition From Pde-5 Inhibitors To Riociguat In Pulmonary Hypertension

被引：0
|
作者：
Weir, N. [1 ]
Brown, A. W. [2 ]
DelaSantina, J. [2 ]
King, C. [2 ]
Lewis, D. [1 ]
Franco-Palacios, D. [2 ]
Nathan, S. D. [1 ]
Shlobin, O. A. [2 ]
机构：
[1] Inova Fairfax Hosp, Falls Church, VA USA
[2] Inova Fairfax Hosp, Kensington, MD USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2282
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Case report: a patient with pulmonary arterial hypertension transitioning from a PDE-5 inhibitor to Riociguat
    Poch, David S.
    BMC PULMONARY MEDICINE, 2016, 16
  • [2] Case report: a patient with pulmonary arterial hypertension transitioning from a PDE-5 inhibitor to Riociguat
    David S. Poch
    BMC Pulmonary Medicine, 16
  • [3] PDE-5 inhibitors lower portal and pulmonary pressure in portopulmonary hypertension
    Deibert, P.
    Bremer, H.
    Roessle, M.
    Kurz-Schmieg, A-K.
    Kreisel, W.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (01) : 220 - 221
  • [4] Inadequate Diagnostic Testing for Patients Started on PDE-5 Inhibitors for Pulmonary Hypertension
    Matusov, Y.
    Wei, K. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Pulmonary Hypertension Therapy and a Systematic Review of Efficacy and Safety of PDE-5 Inhibitors
    Unegbu, Chinwe
    Noje, Corina
    Coulson, John D.
    Segal, Jodi B.
    Romer, Lewis
    PEDIATRICS, 2017, 139 (03)
  • [6] Rationale and study design of the RESPITE trial: Riociguat clinical effects studied in pulmonary arterial hypertension (PAH) patients with insufficient treatment response to PDE-5 inhibitors (PDE-5i)
    Hoeper, Marius
    Benza, Raymond
    Simonneau, Gerald
    Klinger, James
    Langleben, David
    Naeije, Robert
    Corris, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [7] Rationale and Study Design of the RESPITE Trial: Riociguat Clinical Effects Studied in Pulmonary Arterial Hypertension (PAH) Patients With Insufficient Treatment Response to PDE-5 Inhibitors (PDE-5i)
    Hoeper, Marius
    Benza, Raymond
    Klinger, James
    Simonneau, Gerald
    Langleben, David
    Naeije, Robert
    Corris, Paul
    CHEST, 2015, 148 (04)
  • [8] Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors
    Zimmermann, Gregor S.
    von Wulffen, Werner
    Huppmann, Patrick
    Meis, Tobias
    Ihle, Franziska
    Geiseler, Jens
    Leuchte, Hanno H.
    Tufman, Amanda
    Behr, Juergen
    Neurohr, Claus
    RESPIROLOGY, 2014, 19 (05) : 700 - 706
  • [9] Therapy of ED - PDE-5 inhibitors
    Shabsigh, R
    ENDOCRINE, 2004, 23 (2-3) : 135 - 141
  • [10] TREATMENT OF PRIAPISM WITH PDE-5 INHIBITORS
    Romaniuk, M.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S205 - S205
12345